Logo image
Pilot study to evaluate a plasma device for the treatment of onychomycosis
Journal article   Peer reviewed

Pilot study to evaluate a plasma device for the treatment of onychomycosis

S R Lipner, G Friedman and R K Scher
Clinical and experimental dermatology, v 42(3), pp 295-298
Apr 2017
PMID: 28188648

Abstract

Adult Aged Candida albicans - isolation & purification Candidiasis - therapy Female Foot Dermatoses - microbiology Foot Dermatoses - therapy Humans Male Middle Aged Onychomycosis - microbiology Onychomycosis - therapy Patient Satisfaction Pilot Projects Plasma Gases - therapeutic use Tinea - therapy Trichophyton - isolation & purification
Onychomycosis is a fungal infection of the nail unit, and is the most common of the nail disorders. Current therapies for onychomycosis have less than ideal efficacy and have the potential for adverse effects. As previous studies have shown that nonthermal plasma inhibits the in vitro growth of Trichophyton rubrum, we conducted a pilot study on 19 participants with toenail onychomycosis. The primary endpoint was safety of the device, and secondary outcome measures were clinical efficacy and mycological cure. Patient satisfaction was measured using questionnaires at the completion of the study. All but one patient met the primary endpoint of safety and there were no long-term sequelae. The overall clinical cure was 53.8% and the mycological cure was 15.4%. The majority of patients were satisfied with the treatment. Our conclusions are that nonthermal plasma is a safe treatment and may have a beneficial effect on toenail onychomycosis.

Metrics

8 Record Views
32 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Dermatology
Logo image